Finch Therapeutics Group, Inc. (FNCH)

NASDAQ: FNCH · IEX Real-Time Price · USD

2.300

-0.480 (-17.27%)

At close: Apr 24, 2024, 3:59 PM

2.390

+0.090 (3.91%)

After-hours: Apr 24, 2024, 7:54 PM EDT

Finch Therapeutics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0.11	0.86	18.53	7.72	10.15
Revenue Growth (YoY)	-87.57%	-95.35%	140.08%	-23.98%	-
Cost of Revenue	0	0	0	0	0.31
Gross Profit	0.11	0.86	18.53	7.72	9.84
Selling, General & Admin	26.91	36.19	21.24	14.01	7.44
Research & Development	7.2	52.86	57.28	33.14	23.54
Other Operating Expenses	49.86	27.4	0	0	0
Operating Expenses	83.97	116.45	78.52	47.16	30.98
Operating Income	-83.86	-115.59	-59.99	-39.44	-21.14
Interest Expense / Income	-1.57	-0.25	-0.02	0	-0.49
Other Expense / Income	-4.08	-0.7	-1.8	-0.1	0.1
Pretax Income	-78.22	-114.65	-58.16	-39.34	-20.75
Income Tax	-3.46	0	0	0	0
Net Income	-74.75	-114.65	-58.16	-39.34	-20.75
Shares Outstanding (Basic)	2	2	1	0	0
Shares Outstanding (Diluted)	2	2	1	0	0
Shares Change	0.94%	21.65%	381.31%	11.64%	-
EPS (Basic)	-46.59	-72.12	-44.40	-144.90	-85.20
EPS (Diluted)	-46.59	-72.12	-44.40	-144.90	-85.20
Free Cash Flow	-30.18	-77.03	-83.05	-33.96	-18.29
Free Cash Flow Per Share	-18.81	-48.46	-63.56	-125.09	-75.22
Gross Margin	100.00%	100.00%	100.00%	100.00%	96.91%
Operating Margin	-78374.77%	-13425.44%	-323.68%	-510.90%	-208.21%
Profit Margin	-69863.55%	-13315.45%	-313.84%	-509.66%	-204.39%
Free Cash Flow Margin	-28203.74%	-8946.92%	-448.17%	-439.98%	-180.16%
EBITDA	-75.6	-106.37	-55.88	-38.55	-20.76
EBITDA Margin	-70656.07%	-12354.59%	-301.54%	-499.43%	-204.45%
Depreciation & Amortization	4.18	8.53	2.3	0.79	0.48
EBIT	-79.79	-114.9	-58.18	-39.34	-21.24
EBIT Margin	-74565.42%	-13344.72%	-313.95%	-509.66%	-209.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).